Diagnostic Center | September 11, 2024
Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
ALS patients experience neuroinflammation and rapid neurodegeneration
ALS patients experience neuroinflammation and rapid neurodegeneration
The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
The recent inspection covered both cGMP and PAI processes
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
Phase 3 study results will form the basis for future discussions with global regulatory authorities
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The partnership will provide health plans with an out-of-the-box compliance solution for CMS-9115 and CMS-0057 rules
Subscribe To Our Newsletter & Stay Updated
